SG Americas Securities’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67K Buy
78,800
+58,100
+281% +$5.97M ﹤0.01% 2997
2025
Q4
$44K Buy
20,700
+8,800
+74% +$887K ﹤0.01% 3377
2025
Q3
$17K Hold
11,900
﹤0.01% 3299
2025
Q2
$96K Sell
11,900
-18,800
-61% -$1.9M ﹤0.01% 2645
2025
Q1
$168K Sell
30,700
-23,000
-43% -$2.58M ﹤0.01% 2658
2024
Q4
$830K Buy
53,700
+10,700
+25% +$1.22M ﹤0.01% 958
2024
Q3
$855K Buy
43,000
+6,100
+17% +$561K ﹤0.01% 1205
2024
Q2
$99K Buy
36,900
+11,500
+45% +$1.05M ﹤0.01% 2552
2024
Q1
$193K Sell
25,400
-700
-3% -$67.1K ﹤0.01% 2003
2023
Q4
$4K Hold
26,100
﹤0.01% 3042
2023
Q3
$7K Hold
26,100
﹤0.01% 3068
2023
Q2
$12K Hold
26,100
﹤0.01% 2191
2023
Q1
$28K Sell
26,100
-28,100
-52% -$3.86M ﹤0.01% 3122
2022
Q4
$404K Sell
54,200
-22,500
-29% -$3.46M ﹤0.01% 1700
2022
Q3
$553K Buy
76,700
+35,500
+86% +$5.43M 0.01% 1464
2022
Q2
$372K Buy
41,200
+6,000
+17% +$917K ﹤0.01% 2211
2022
Q1
$114K Sell
35,200
-20,800
-37% -$3.5M ﹤0.01% 2716
2021
Q4
$739K Buy
+56,000
New +$15.3M ﹤0.01% 1864

Other funds holding BNTX

SG Americas Securities's BNTX Position: Q1 2026 in Review

SG Americas Securities reduced its BioNTech (BNTX) stake by 26% in Q1 2026, selling an estimated $9.77M and leaving 270,245 shares worth $24M. The position accounts for 0.03% of the portfolio, ranked #477.

SG Americas Securities first reported a position in BNTX in Q1 2020 and has held it in 25 quarters since. The position peaked at $45.5M in Q4 2021. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • SG Americas Securities held 270,245 shares of BioNTech worth $24M as of Q1 2026.
  • SG Americas Securities sold 95,088 BioNTech shares in Q1 2026, an estimated $9.77M.
  • BioNTech made up 0.03% of SG Americas Securities's portfolio in Q1 2026, its #477 holding.
  • SG Americas Securities first reported a position in BioNTech in Q1 2020 and has held it in 25 quarters since.
  • SG Americas Securities's BioNTech position peaked at $45.5M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.